88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion SHANGHAI , Aug. 31, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), ... 2026-08-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving ... 2026-08-31T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management - Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. ... 2026-08-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tycoon Group Sustains Profitability: 2026 Interim Results Net Profit Surges 183% Year-on-Year Business Demonstrates Strong Resilience, ... 2026-08-29T Health Care/Hospital Medical/Pharmaceuticals Retail
INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces ZIBO, China , Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion ... 2026-08-29T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
LifeTech Scientific Corporation Announces 2026 Interim Results HONG KONG , Aug. 29, 2026 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), ... 2026-08-29T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla ® (ado-trastuzumab emtansine) in major regulated markets. ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities The partnership unites global clinical operations excellence with advanced digital ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma SHANGHAI , Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering SYDNEY , Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies ... 2026-08-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals